Dr. Stanca Birlea
Centrul Medical Anastasios Zalau
Zalau
Dermatovenerologie, Medic Primar
Vezi disponibilitateTestimoniale (46)
Arii de expertiză
-Afectiuni pigmentare (boli depigmentante si hiperpigmentante) -Patologie par (alopecii) si unghii -Boli immune si autoimmune complexe: psoriasis, buloze cutanate, etc -Boli de tesut conjunctiv -Patologia glandelor sebacee si a celor sudoripare apocrine si ecrine (acne, rozacee, hidradenita supurativa, hyperhidroza, etc) -Tumori cutanate benigne si maligne (cancere de piele); -Dermatoscopie, monitorizarea alunițelor si a altor neoplasme cutanate
Interpretare analize
- Analize laborator (sânge, endocrini, infecțioase etc)Documente medicaleImagistică indisponibil
- DermatoscopieDocumente medicaleImagistică indisponibil
Despre mine
Locuri de muncă
Centrul Medical Anastasios Zalau
Educație
Licență
Universitatea de Medicina si Farmacie Iuliu Hatieganu Cluj-Napoca1989 - 1995
Medic specialitate dermato-venerologie
Universitatea de Medicina si Farmacie Iuliu Hatieganu Cluj-Napoca1995 - 2001
Medical Doctor
Universitatea de Medicina si Farmacie Iuliu Hatieganu Cluj-Napoca2001 - 2004
Articole medicale
Certificări
Dermatoscopie - Dermatoscopy Excellence Course
International Dermoscopy Society
Membru
- Membru Societatea Romana de Dermatologie
- Colegiul Medicilor din Romania
- Panamerican Society of Pigment Cell Research
- International Dermoscopy Society
- European Academy of Dermatology and Venereology
Conferințe
European Academy of Dermatology and Venereology, 2025
Societatea Europeana de Dermatologie si Venerologie
Paris, France
Colorado Dermatology Society Meeting, 2023-2025
Colorado Dermatologic Society
Denver, Colorado, USA
Society of Investigative Dermatology Meeting, 2024
Society of Investigative Dermatology
Dallas, Texas, USA
Global Vitiligo Foundation Meeting, 2024
Global Vitiligo Foundation
San Diego, California, USA
Articole științifice
Phosphodiesterase-4 inhibitors increase pigment cells proliferation and melanization in cultured melanocytes and within a 3D skin equivalent model.
Journal of Investigative Dermatology, 2025; 145(4):883-896. Goldstein NB, Berk Z, Tomb L, Hu J, ..., and Birlea SA.
Vitiligo non-responding lesions to Narrow Band UVB have intriguing cellular and molecular abnormalities that prevent epidermal repigmentation.
Pigment Cell and melanoma research, 2024; 37(3):378-390. Goldstein NB, Steel A, Tomb L, Berk Z, ..., and Birlea SA
Melanocyte precursors in the hair follicle bulge of repigmenting vitiligo skin are controlled by RHO-GTPase, KCTD10 and CTNNB1 signaling.
Journal of Investigative Dermatology, 2020; 141(3): 638-647. Goldstein NB, Steel A, Barbulescu C, Koster MI, Wright MJ, ..., and Birlea SA.
Harnessing the Power of Regenerative Therapy for Vitiligo and Alopecia Areata
Journal of Investigative Dermatology, 2019; 140: 29-37. Barbulescu CC, Goldstein NB, Roop DR, Norris DA, Birlea SA
Symmetric multilocular epidermoid cysts on the face: an unusual presentation of a common lesion.
Journal of American Academy of Dermatology, 2018; 4:337-339. Mayer JE, Miller MD, Birlea SA
Repigmentation of human vitiligo skin by NBUVB is controlled by transcription of GLI1 and activation of B-catenin pathway in the hair follicle bulge
Journal of Investigative Dermatology, 2018; 138:657-668. Goldstein NB, Koster MI, Jones KL, Gao B, Hoaglin LG,..., Birlea SA
S100B: Correlation with Active Vitiligo Depigmentation.
Journal of Investigative Dermatology 2017; 137:1408-1410. Birlea SA
Trends in regenerative medicine: repigmentation in vitiligo through melanocyte stem cell mobilization.
Medicinal Research Reviews, 2016; 37(4):907-935. Birlea SA, Costin GE, Roop DR, Norris DA.
Biphasic pro-melanogenic and pro-apoptotic effects of all-trans-retinoic acid (ATRA) on human melanocytes: Time-course study.
Journal of Dermatological Science, 2013; 72:168-176. Baldea I, Costin GE, Olteanu D, Shelmann Y, Norris DA, Birlea SA.
Association of generalized vitiligo with MHC class II loci in patients from the Indian subcontinent
Journal of Dermatological Science, 2012; 133:1369-1372. Birlea SA, Ahmad FJ, Uddin RM, Ahmad S, Pal SS,..., and Sprtiz RA.
Cellular and molecular basis of regenerative therapy using electromagnetic fields
Current Molecular Medicine, 2011; 12:14-26. Costin G-E, Birlea SA, Norris DA
Recalcitrant Grysbovski’s keratoacanthomas with good response to cimetidine
American Journal of Medicine, 2010; 123:9-10. Baican A, Norris DA, Birlea SA.
Genomewide association study of generalized vitiligo in an isolated European founder population identifies SMOC2, in close proximity of IDDM8.
Journal of Investigative Dermatology, 2009; 130: 798-803. Birlea SA, Gowan K, Fain PR, Spritz RA.
What is the mechanism for melasma that accompanies human pregnancy?
IUBMB Life, 2006; 58: 55-57. Costin GE, Birlea SA.
/498x114/landing-page/medic-chat-logo-new.png)